1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Phio Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumoral PH-762 for Cutaneous Carcinoma PH-762 - Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin | Phase 1 | Completed | Phio Pharmaceuticals Inc. | 22 | 2023-11-07 | 2026-09-21 |
| Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2 - HNSCC, Melanoma | Phase 1 | Active not recruiting | AgonOx, Inc. | 18 | 2023-06-19 | 2026-01-08 |
Melanoma (2) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Urogenital Neoplasms (1)
Interleukin-2 (1)
United States (2)
Linda Mahoney (1)